Tag: roche diagnostics

November 4, 2019 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Pharmacogenetic testing is gaining acceptance by a growing number of health insurers. On Oct. 1, UnitedHealthcare (UHC) began coverage of genetic tests that help physicians identify the anti-depressant drugs most likely to benefit their patients. UHC’s policy also extends coverage to multi-gene testing for antipsychotic drugs. In writing about this decision, www.clinicalomics.com said, “UnitedHealthcare’s policy

View Article

September 3, 2019 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Two more clinical laboratory organizations that used American Medical Collection Agency (AMCA) to handle their lab test claims announced in July that their patients’ data was breached. Inform Diagnostics of Irving, Texas, disclosed that the data of 173,716 patients was compromised. Within days of that announcement, CompuNet Clinical Laboratories of Moraine, Ohio, stated that about 110,000

View Article

August 12, 2019 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Add eight more laboratories to the list of lab companies whose patient data were breached when the American Medical Collection Agency was hacked. According to HealthITSecurity, in recent weeks, these labs reported breaches of their patient records:

Natera
American Esoteric Labs
CBLPath
South Texas Dermatopathology
Seacoast Pathology
Arizona Dermatopathology
Laboratory of Dermatopathology ADX

MORE ON: Patient Data Breach

It

View Article

August 20, 2018 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

There is a new sector in the clinical laboratory industry. It is called “global direct-to-consumer (DTC) genetic health testing” by Kalorama Information, a market research firm based in Rockville, Md. In a recent report, Kalorama says this sector is comprised of the direct-to-consumer genetic tests which are initiated by the consumer, meaning that the consumer decides

View Article

January 22, 2018 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

In a first for Australia, a pathology lab was given authorization to use patient-collected cervical specimens from eligible women for cervical cancer screening purposes. VCS Pathology of Melbourne, Victoria, was given this authorization by Australia’s National Association of Testing Authorities (NATA). Other pathology labs in Australia are expected to be granted similar authorization in coming

View Article